ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Nasal Polyps
Rhinitis
Rhinosinusitis
Sinusitis
Conjunctivitis

Asthma trials near Austin, TX, USA:

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...

Active, not recruiting
Severe Asthma
Drug: Placebo
Drug: Verekitug (UPB-101)

Phase 2

Upstream Bio

Marble Falls, Texas, United States and 155 other locations

in male and female participants aged 18 to 65 years (inclusive) with asthma.This study consists of a screening/run-in period, a treatment pe...

Enrolling
Asthma
Combination Product: Intervention: Ventolin Evohaler
Combination Product: Intervention: AS MDI

Phase 2

AstraZeneca
AstraZeneca

Austin, Texas, United States and 24 other locations

is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...

Enrolling
Asthma
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Austin, Texas, United States and 252 other locations

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Enrolling
Moderate to Severe Asthma
Drug: ICS-LABA
Other: placebo

Phase 2

Incyte
Incyte

Austin, Texas, United States and 84 other locations

and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...

Enrolling
Asthma
Drug: Placebo
Drug: Atuliflapon

Phase 2

AstraZeneca
AstraZeneca

Austin, Texas, United States and 382 other locations

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...

Enrolling
Asthma
Drug: Short-Acting Beta Agonists (SABA)
Drug: Fluticasone/salmeterol

Phase 2

Sanofi
Sanofi

Austin, Texas, United States of America and 159 other locations

administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled c...

Enrolling
Asthma
Device: Inhaler
Drug: AZD8630

Phase 2

AstraZeneca
AstraZeneca

Austin, Texas, United States and 229 other locations

safety, and tolerability of add-on therapy with SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-severe asthma...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Lunsekimig

Phase 2

Sanofi
Sanofi

Austin, Texas, United States of America and 161 other locations

Locations recently updated

inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...

Enrolling
Asthma
Drug: Albuterol sulfate
Drug: TEV-56248

Phase 3

Teva Pharmaceuticals
Teva Pharmaceuticals

Austin, Texas, United States and 371 other locations

The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electron...

Enrolling
Asthma
Drug: Placebo
Drug: FP

Phase 3

Teva Pharmaceuticals
Teva Pharmaceuticals

Austin, Texas, United States and 53 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems